These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 25684226

  • 1. Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition.
    Nori S, Okada Y, Nishimura S, Sasaki T, Itakura G, Kobayashi Y, Renault-Mihara F, Shimizu A, Koya I, Yoshida R, Kudoh J, Koike M, Uchiyama Y, Ikeda E, Toyama Y, Nakamura M, Okano H.
    Stem Cell Reports; 2015 Mar 10; 4(3):360-73. PubMed ID: 25684226
    [Abstract] [Full Text] [Related]

  • 2. Human neural progenitors derived from integration-free iPSCs for SCI therapy.
    Liu Y, Zheng Y, Li S, Xue H, Schmitt K, Hergenroeder GW, Wu J, Zhang Y, Kim DH, Cao Q.
    Stem Cell Res; 2017 Mar 10; 19():55-64. PubMed ID: 28073086
    [Abstract] [Full Text] [Related]

  • 3. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
    Kobayashi Y, Okada Y, Itakura G, Iwai H, Nishimura S, Yasuda A, Nori S, Hikishima K, Konomi T, Fujiyoshi K, Tsuji O, Toyama Y, Yamanaka S, Nakamura M, Okano H.
    PLoS One; 2012 Mar 10; 7(12):e52787. PubMed ID: 23300777
    [Abstract] [Full Text] [Related]

  • 4. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice.
    Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, Kobayashi Y, Fujiyoshi K, Koike M, Uchiyama Y, Ikeda E, Toyama Y, Yamanaka S, Nakamura M, Okano H.
    Proc Natl Acad Sci U S A; 2011 Oct 04; 108(40):16825-30. PubMed ID: 21949375
    [Abstract] [Full Text] [Related]

  • 5. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
    Okubo T, Iwanami A, Kohyama J, Itakura G, Kawabata S, Nishiyama Y, Sugai K, Ozaki M, Iida T, Matsubayashi K, Matsumoto M, Nakamura M, Okano H.
    Stem Cell Reports; 2016 Oct 11; 7(4):649-663. PubMed ID: 27666789
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increase of sensitivity to mechanical stimulus after transplantation of murine induced pluripotent stem cell-derived astrocytes in a rat spinal cord injury model.
    Hayashi K, Hashimoto M, Koda M, Naito AT, Murata A, Okawa A, Takahashi K, Yamazaki M.
    J Neurosurg Spine; 2011 Dec 11; 15(6):582-93. PubMed ID: 21854127
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic Application of Placental Mesenchymal Stem Cells Reprogrammed Neurospheres in Spinal Cord Injury of SCID.
    Sabapathy V, Herbert FJ, Kumar S.
    Methods Mol Biol; 2017 Dec 11; 1553():91-113. PubMed ID: 28229410
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of glial transplantation on functional recovery following acute spinal cord injury.
    Lee KH, Yoon DH, Park YG, Lee BH.
    J Neurotrauma; 2005 May 11; 22(5):575-89. PubMed ID: 15892602
    [Abstract] [Full Text] [Related]

  • 14. Connexin 50 Expression in Ependymal Stem Progenitor Cells after Spinal Cord Injury Activation.
    Rodriguez-Jimenez FJ, Alastrue-Agudo A, Stojkovic M, Erceg S, Moreno-Manzano V.
    Int J Mol Sci; 2015 Nov 06; 16(11):26608-18. PubMed ID: 26561800
    [Abstract] [Full Text] [Related]

  • 15. Injectable hydrogel promotes early survival of induced pluripotent stem cell-derived oligodendrocytes and attenuates longterm teratoma formation in a spinal cord injury model.
    Führmann T, Tam RY, Ballarin B, Coles B, Elliott Donaghue I, van der Kooy D, Nagy A, Tator CH, Morshead CM, Shoichet MS.
    Biomaterials; 2016 Mar 06; 83():23-36. PubMed ID: 26773663
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic potential of induced pluripotent stem cells for spinal cord injury].
    Nori S, Tsuji O, Okada Y, Toyama Y, Okano H, Nakamura M.
    Brain Nerve; 2012 Jan 06; 64(1):17-27. PubMed ID: 22223498
    [Abstract] [Full Text] [Related]

  • 17. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.
    Kawabata S, Takano M, Numasawa-Kuroiwa Y, Itakura G, Kobayashi Y, Nishiyama Y, Sugai K, Nishimura S, Iwai H, Isoda M, Shibata S, Kohyama J, Iwanami A, Toyama Y, Matsumoto M, Nakamura M, Okano H.
    Stem Cell Reports; 2016 Jan 12; 6(1):1-8. PubMed ID: 26724902
    [Abstract] [Full Text] [Related]

  • 18. iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury.
    Nagoshi N, Okano H.
    Cell Mol Life Sci; 2018 Mar 12; 75(6):989-1000. PubMed ID: 28993834
    [Abstract] [Full Text] [Related]

  • 19. Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury.
    Li K, Javed E, Scura D, Hala TJ, Seetharam S, Falnikar A, Richard JP, Chorath A, Maragakis NJ, Wright MC, Lepore AC.
    Exp Neurol; 2015 Sep 12; 271():479-92. PubMed ID: 26216662
    [Abstract] [Full Text] [Related]

  • 20. Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord.
    Lepore AC, Fischer I.
    Exp Neurol; 2005 Jul 12; 194(1):230-42. PubMed ID: 15899260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.